Revance Therapeutics, Inc. reports

Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Nashville, TN
SEC filing record 1 source field available
Fiscal year end
31 December
Revance Therapeutics, Inc. has filed 947 SEC EDGAR filings since 23 Dec 2009

SEC filing history

Showing 401-425 of 946 matching filings.

Per page
25
Current page
17
4

FORM 4

Filing date
30 Oct 2020
Reporting date
29 Oct 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
15 Oct 2020
Reporting date
23 Jul 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
02 Oct 2020
Reporting date
30 Sep 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
02 Oct 2020
Reporting date
30 Sep 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
02 Oct 2020
Reporting date
30 Sep 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
02 Oct 2020
Reporting date
30 Sep 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
02 Oct 2020
Reporting date
30 Sep 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
30 Sep 2020
Reporting date
28 Sep 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
4/A

FORM 4/A

Filing date
30 Sep 2020
Reporting date
23 Jul 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-88023

SEC SCHEDULE 13G

Filing date
10 Aug 2020
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
27 Jul 2020
Reporting date
23 Jul 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
3

FORM 3

Filing date
27 Jul 2020
Reporting date
23 Jul 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
S-8 File 333-240061

S-8

Filing date
24 Jul 2020
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
02 Jul 2020
Reporting date
30 Jun 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
02 Jul 2020
Reporting date
30 Jun 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
EFFECT File 333-239059

EFFECT filing

Filing date
24 Jun 2020
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
424B3 File 333-239059

424B3

Filing date
24 Jun 2020
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
CORRESP

CORRESP filing

Filing date
23 Jun 2020
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
S-4/A File 333-239059

AMENDMENT NO. 1 TO FORM S-4

Filing date
23 Jun 2020
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
UPLOAD

UPLOAD filing

Filing date
17 Jun 2020
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .